These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31642844)

  • 1. Oily core/amphiphilic polymer shell nanocapsules change the intracellular fate of doxorubicin in breast cancer cells.
    Coelho JM; Camargo NS; Ganassin R; Rocha MCO; Merker C; Böttner J; Estrela-Lopis I; Py-Daniel KR; Jardim KV; Sousa MH; Ombredane AS; Joanitti GA; Silva RC; Azevedo RB; Longo JPF; Muehlmann LA
    J Mater Chem B; 2019 Oct; 7(41):6390-6398. PubMed ID: 31642844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocapsules for the co-delivery of selol and doxorubicin to breast adenocarcinoma 4T1 cells in vitro.
    Ganassin R; Merker C; Rodrigues MC; Guimarães NF; Sodré CSC; Ferreira QDS; da Silva SW; Ombredane AS; Joanitti GA; Py-Daniel KR; Zhang J; Jiang CS; de Morais PC; Mosiniewicz-Szablewska E; Suchocki P; Longo JPF; Meijer J; Estrela-Lopis I; de Azevedo RB; Muehlmann LA
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2002-2012. PubMed ID: 29179603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selol nanocapsules with a poly(methyl vinyl ether-co-maleic anhydride) shell conjugated to doxorubicin for combinatorial chemotherapy against murine breast adenocarcinoma in vivo.
    Ganassin R; Horst FH; Camargo NS; Chaves SB; Morais PC; Mosiniewicz-Szablewska E; Suchocki P; Figueiró Longo JP; Azevedo RB; Muehlmann LA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1046-1052. PubMed ID: 29842818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Evaluation of Core-Shell Nanocarrier System for Enhancing the Cytotoxicity of Doxorubicin/Metformin Combination Against Breast Cancer Cell Line.
    Ibrahim A; Khalil IA; El-Sherbiny IM
    J Pharm Sci; 2022 Sep; 111(9):2581-2591. PubMed ID: 35613685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(sebacic anhydride) nanocapsules as carriers: effects of preparation parameters on properties and release of doxorubicin.
    Bagherifam S; Griffiths GW; Mælandsmo GM; Nyström B; Hasirci V; Hasirci N
    J Microencapsul; 2015; 32(2):166-74. PubMed ID: 25323326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoration of a Poly(methyl vinyl ether-co-maleic anhydride)-Shelled Selol Nanocapsule with Folic Acid Increases Its Activity Against Different Cancer Cell Lines
    Ganassin R; Souza LR; Py-Daniel KR; Longo JPF; Coelho JM; Rodrigues MC; Jiang CS; Gu J; Morais PC; Mosiniewicz-Szablewska E; Suchocki P; Báo SN; Azevedo RB; Muehlmann LA
    J Nanosci Nanotechnol; 2018 Jan; 18(1):522-528. PubMed ID: 29768877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteinizing hormone-releasing hormone targeted poly(methyl vinyl ether maleic acid) nanoparticles for doxorubicin delivery to MCF-7 breast cancer cells.
    Varshosaz J; Jahanian-Najafabadi A; Ghazzavi J
    IET Nanobiotechnol; 2016 Aug; 10(4):206-14. PubMed ID: 27463791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid formulation containing doxorubicin-loaded lipid-core nanocapsules: Cytotoxicity in human breast cancer cell line and in vitro uptake mechanism.
    Antonow MB; Asbahr ACC; Raddatz P; Beckenkamp A; Buffon A; Guterres SS; Pohlmann AR
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():374-382. PubMed ID: 28482541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-loaded nanosized micelles of a star-shaped poly(ε-caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer.
    Cuong NV; Hsieh MF; Chen YT; Liau I
    J Biomater Sci Polym Ed; 2011; 22(11):1409-26. PubMed ID: 20594418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin.
    Chen CK; Wang Q; Jones CH; Yu Y; Zhang H; Law WC; Lai CK; Zeng Q; Prasad PN; Pfeifer BA; Cheng C
    Langmuir; 2014 Apr; 30(14):4111-9. PubMed ID: 24665861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
    Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
    J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.
    Pramod PS; Shah R; Jayakannan M
    Nanoscale; 2015 Apr; 7(15):6636-52. PubMed ID: 25797322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
    Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
    Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
    Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
    Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin.
    Gupta B; Pathak S; Poudel BK; Regmi S; Ruttala HB; Gautam M; Lee JS; Jeong JH; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2017 Jul; 155():83-92. PubMed ID: 28410515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromelain-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Formulation, Chemical Structure and Antiproliferative Effect Against Human Breast Cancer Cells (MCF-7).
    Oliveira CP; Prado WA; Lavayen V; Büttenbender SL; Beckenkamp A; Martins BS; Lüdtke DS; Campo LF; Rodembusch FS; Buffon A; Pessoa A; Guterres SS; Pohlmann AR
    Pharm Res; 2017 Feb; 34(2):438-452. PubMed ID: 27981451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.